Search filters

List of works by Nathan Clumeck

A double-blind, placebo-controlled trial of maraviroc in treatment-experienced patients infected with non-R5 HIV-1.

scientific article

A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine

scientific article published in June 2008

A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial.

scientific article

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients

scientific article

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression ⬇️

scientific article

Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study.

scientific article

Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events

scientific article

Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection

scientific article published in July 2007

Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results

scientific article published on 29 January 2016

Characteristics of non‐AIDS‐defining malignancies in the HAART era: a clinico‐epidemiological study ⬇️

scientific article published on March 28, 2011

Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study

scientific article

Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir versus continued HAART: the Trizal study

scientific article

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

scientific article

Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection

scientific article published on November 2013

Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection

scientific article published in January 2008

Effects of switching to protease inhibitor monotherapy on nucleoside analogue-related adverse events.

scientific article

Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings

scientific article published on March 2014

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials ⬇️

scientific article published on April 24, 2012

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind,

scientific article published on 14 March 2016

Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen

scientific article published in March 2007

Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study)

scientific article

First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting

scientific article published on May 2014

HIV and syphilis: when to perform a lumbar puncture

scientific article published in March 2007

Health-related quality of life with enfuvirtide (ENF; T-20) in combination with an optimized background regimen

scientific article published in September 2004

Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study

scientific article published on 7 February 2008

High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus

scientific article

High-risk human papillomavirus infection in HIV-positive African women living in Europe

scientific article published on 14 February 2013

Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infection

scientific article published in November 2006

Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors

scientific article

Maraviroc for previously treated patients with R5 HIV-1 infection

scientific article

Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection

scientific article published on March 2010

Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study

scientific article

Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trials

scientific article published in November 2007

Predictors of Virological Outcome and Safety in Primary HIV Type 1-Infected Patients Initiating Quadruple Antiretroviral Therapy: QUEST GW PROB3005

article

Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.

scientific article published in March 2008

Prolonged antiretroviral therapy is associated with fewer anal high-grade squamous intraepithelial lesions in HIV-positive MSM in a cross-sectional study

scientific article published on 30 March 2016

Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial

scientific article published on 20 August 2003

Resistance at Virological Failure Using Boosted Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors As First-Line Antiretroviral Therapy—Implications for Sustained Efficacy of ART in Resource-Limited Settings ⬇️

scientific article published on June 15, 2013

Rilpivirine vs. efavirenz in HIV-1 patients with baseline viral load 100,000 copies/ml or less: week 48 phase III analysis

scientific article published on March 2013

Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001.

scientific article

Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials ⬇️

scientific article published on August 27, 2010

Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.

scientific article published on 17 December 2015

Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients

scientific article

Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women

scientific article published on 5 March 2013

Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection

scientific article

TMC114/ritonavir substitution for protease inhibitor(s) in a non-suppressive antiretroviral regimen: a 14-day proof-of-principle trial

scientific article published in June 2005

The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml

scientific article published in January 2010

The challenge: streamlining HIV treatment and care while improving outcomes

scientific article

Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line

scientific article published on 14 April 2016

Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system

scientific article published in December 2004

When should antiretroviral therapy for HIV be started?

scientific article published on January 2007

Paulina is supported by:

About Paulina

Help